Elanco (ELAN) CFO Robert VanHimbergen Receives Stock Award

What Happened Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health Inc., received a grant of 7.909 deferred stock units (DSUs) on July 24, 2026. The units were recorded at $24.91 per share for a total grant value of approximately $197. The transaction is reported as a derivative award (code A) rather than an open-market buy.

Key Details

• Transaction date: 2026-07-24; Filing date: 2026-07-28 (Form 4 accession 0001724169-26-000035).
• Award: 7.909 deferred stock units @ $24.91 each; aggregate value ≈ $197.
• Transaction type: Award/Grant (derivative units), reported under code A.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnotes:
  • F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  • F2: DSUs settle in cash or shares following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
• No 10b5-1 plan, tax-withholding sale, or late-filing flag is indicated in the provided details.

Context Deferred stock units are a form of compensation deferral and do not reflect an immediate cash purchase or sale of company stock. They typically convert to shares or cash at a future date (e.g., upon termination or a preset settlement date) and are generally considered routine executive compensation rather than a direct market sentiment signal.